Companies/Aurora Spine Corporation

Company profile

Aurora Spine Corporation

OTC: ASAPF · Healthcare · Medical - Devices

Canadian filerHQ Toronto, ONReports USD

#552 of 1,394 Healthcare companies by revenue51st-percentile growth

EA Score

65B

FH 69DQ —GM 61SS 48

v0.1 · 45/100 weight · provisional

↑ Piotroski F, growth stability · ↓ workforce scale, balance-sheet leverage

Methodology →

Revenue TTM

$18.4M

Rev growth YoY (TTM)

+2.9%

Net income (FY)

-$743.9k

Employees

Market cap

$13.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$18.7M$18.7M2025

Net income-$743.9k-$743.9k2025

Operating income-$335.8k-$335.8k2025

Total assets$10.4M$10.4M2025

Liabilities$6.6M$6.6M2025

Equity$3.8M$3.8M2025

Revenue trend

FY2018 – FY2025 · USD

$8.7M

FY18

$11.2M

FY19

$8.6M

FY20

$10.5M

FY21

$14.9M

FY22

$14.5M

FY23

$17.6M

FY24

$18.7M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Aurora Spine Corporation booked $18.7M in FY2025 revenue, growing 6.4% year over year — about the middle of the pack among Healthcare companies we track, at a -4.0% net margin.

Peers · Healthcare

Pharma-Bio Serv, Inc.58C Bionano Genomics, Inc.47D Vyome Holdings, Inc.33D Biofrontera Inc.46D

Key facts

CEOTrent J. Northcutt

SectorHealthcare

IndustryMedical - Devices

HeadquartersToronto, ON

ExchangeOTC: ASAPF

Employees18

IPO date2013-09-26

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.